3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 1/2
3
Phase 4
1
Phase 2/3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urologic Diseases
1
Nephritis
1
Kidney Diseases
1
Immune System Diseases
1
Glomerulonephritis, IGA
1
Glomerulonephritis
1
Autoimmune Diseases
1
Interventions
Metformin
16
Cyclophosphamide
15
Drug Therapy
14
Dexamethasone
14
Cisplatin
14
Cytarabine
11
Gemcitabine
10
Radiotherapy
9
Carboplatin
9
Vincristine
8
Paclitaxel
8
Oxaliplatin
8
Idarubicin
8
Etoposide
8
Docetaxel
8
ulipristal acetate
7
icotinib
7
Sodium Chloride
7
Methotrexate
7
Fluorouracil
7
Dexmedetomidine
7
entecavir
6
Thalidomide
6
Surgical Procedures, Operative
6
Sorafenib
6
Pemetrexed
6
Leuprolide
6
Granulocyte Colony-Stimulating Factor
6
Epirubicin
6
Doxorubicin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Unknown
×
Hydroxychloroquine
×
Clear all
NCT02765594
2017-09-20
HCQIgAN
Peking Union Medical College Hospital
Phase 4
Unknown
98 enrolled